close
MENU
Investment
2 mins to read

Rua Biosciences mulls legal action over non-payment

The prospective owner has not paid the $1.3m purchase price for Rua’s Gisborne manufacturing facility.

Rua Bioscience CEO Paul Naske.

Listed medicinal cannabis company Rua Biosciences is considering its legal options after the buyer of its Gisborne manufacturing facility failed to pay the $1.3 million purchase price.

The contract was due to be paid in full by 5pm on Wednesday by the purchaser, Awa Ora Genesis Kaitiaki Harakeke

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Thu, 31 Oct 2024
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Rua Biosciences mulls legal action over non-payment
Investment,
106498
true